Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,353.00
-24.00 (-1.74%)
Jun 23, 2025, 4:59 PM CET
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
8.45M DKK
Profits / Employee
2.98M DKK
Market Cap
84.85B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 77,349 |
| Coloplast | 16,639 |
| Demant | 22,639 |
| ALK-Abelló | 2,753 |
| H. Lundbeck | 5,707 |
| Zealand Pharma | 335 |
| Ambu A/S | 5,196 |
| Embla Medical | 4,061 |
Genmab News
- 5 hours ago - Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One - Seeking Alpha
- 6 hours ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 6 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 6 days ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 7 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 8 days ago - Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT) - GlobeNewsWire
- 8 days ago - Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT) - Business Wire
- 11 days ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire